Role of Modified Lipoproteins in Diabetic Macroangiopathy

Witztum, Joseph L

doi:10.2337/diab.46.2.S112

Article navigation

Articles| September 01 1997

Role of Modified Lipoproteins in Diabetic Macroangiopathy

Joseph L Witztum

University of California

San Diego, La Jolla, California

Search for other works by this author on:

This Site

PubMed

Google Scholar

Address correspondence and reprint requests to Joseph L. Witztum, University of California, San Diego, Department of Medicine 0682, 9500 Gilman Dr., La Jolla, CA 92093

Diabetes 1997;46(Supplement_2):S112–S114

https://doi.org/10.2337/diab.46.2.S112

PubMed:

9285511

Role of Modified Lipoproteins in Diabetic Macroangiopathy

Article PDF first page preview

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

Role of Modified Lipoproteins in Diabetic Macroangiopathy

Article PDF first page preview

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

This Feature Is Available To Subscribers Only